Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 49.0817 on 05-09-2025 at 18:15:01
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 359.00 at 49.02901
Day's Volume: 104,214
Last Close: 49.0817
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 50.42964
Market Capitalisation: -
VWAP: 48.92322
Shares in Issue: 430.70m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 359 49.02901 OTC Trade
17:47:35 - 05-Sep-25
Unknown* 47 49.0817 SI Trade
Negotiated Trade
17:32:47 - 05-Sep-25
Unknown* 1,395 48.88 OTC Trade
17:21:51 - 05-Sep-25
Unknown* 3,428 48.9191 OTC Trade
17:16:57 - 05-Sep-25
Unknown* 479 48.87267 OTC Trade
17:12:25 - 05-Sep-25
Unknown* 464 48.87267 OTC Trade
17:12:25 - 05-Sep-25
Unknown* 145 48.94443 OTC Trade
17:05:35 - 05-Sep-25
Unknown* 203 48.87025 OTC Trade
16:59:15 - 05-Sep-25
Unknown* 639 48.97601 SI Trade
Negotiated Trade
16:58:23 - 05-Sep-25
Unknown* 68 49.01074 OTC Trade
16:47:47 - 05-Sep-25
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
5th Sep 2025 (Fri) 49.0817 49.0817 49.0817 49.0817 104,214
4th Sep 2025 (Thu) 49.53186 49.53186 49.53186 49.53186 35,144
3rd Sep 2025 (Wed) 49.37658 49.37658 49.37658 49.37658 115,581
2nd Sep 2025 (Tue) 49.27651 49.27651 49.27651 49.27651 94,277
1st Sep 2025 (Mon) 50.07939 50.07939 50.07939 50.07939 56,867
29th Aug 2025 (Fri) 50.30 50.30 50.30 50.30 367,936
28th Aug 2025 (Thu) 50.30 50.30 50.30 50.30 45,662
27th Aug 2025 (Wed) 50.42964 50.42964 50.42964 50.42964 75,798
26th Aug 2025 (Tue) 50.15778 50.15778 50.15778 50.15778 53,185
25th Aug 2025 (Mon) 49.95954 49.95954 49.95954 49.95954 0
22nd Aug 2025 (Fri) 49.95954 49.95954 49.95954 49.95954 45,923
21st Aug 2025 (Thu) 48.84598 48.84598 48.84598 48.84598 42,243
20th Aug 2025 (Wed) 48.65961 48.65961 48.65961 48.65961 29,545
19th Aug 2025 (Tue) 48.67668 48.67668 48.67668 48.67668 58,693
18th Aug 2025 (Mon) 47.97 47.97 47.97 47.97 36,125
15th Aug 2025 (Fri) 47.82779 47.82779 47.82779 47.82779 34,336
14th Aug 2025 (Thu) 47.57822 47.57822 47.57822 47.57822 104,966
13th Aug 2025 (Wed) 47.56395 47.56395 47.56395 47.56395 83,389
12th Aug 2025 (Tue) 47.30624 47.30624 47.30624 47.30624 663,579
11th Aug 2025 (Mon) 47.07566 47.07566 47.07566 47.07566 29,008
8th Aug 2025 (Fri) 48.26607 48.26607 48.26607 48.26607 122,902
7th Aug 2025 (Thu) 49.36854 49.36854 49.36854 49.36854 308,914
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value9,208.21
Change-8.66

Login to your account

Forgot Password?

Not Registered